Gefapixant Promising for Relief of Unexplained Chronic Cough
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.